9th annual Graylyn Conference: Women's Cognitive Health

第九届格雷林年度会议:女性认知健康

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Women's Health Center of Wake Forest University Health Sciences began annual Graylyn Conferences on Women's Health for cutting-edge women's health research in 1995. Past conferences focused on the effects of estrogen on the pathogenesis and prevention of atherosclerosis and cognitive decline, and have successfully disseminated new research on estrogen, heart disease and cognition. This year, we are expanding our focus to include an entire day devoted to hormone therapy and cognition. Women's Cognitive Health will incorporate new issues in cognitive health, providing an overview of the risks and benefits of hormones and how they affect women's cognitive health. The conference will also examine the effects of diseases more prevalent in women and their treatments on cognitive functioning, explore advances in basic science of cognitive decline, and investigate advances in diagnostic criteria, and new preventions and treatments. The conference goal is to bring together leaders in the field to review current knowledge to guide efforts toward promising research avenues. Women's Cognitive Health will be held October 29-31, 2003 in Winston-Salem, NC. Meetings will be held in the handicapped-accessible Graylyn Conference Center, where 40 rooms have been reserved for out-of-town guests. Participants can fly into the Piedmont Triad International Airport in Greensboro, NC. An airport shuttle service will be provided for speakers and is available to participants for $39, round-trip. Registration is limited to 100 speakers and attendees to promote interaction. A poster session will highlight the most recent advances in methodology and research on cognitive decline and dementia, and awards will be given to the top student and junior faculty submissions to encourage work by new investigators. Goals and Objectives: 1. Widen pool of knowledge from which to draw solutions by convening a small group who has knowledge particular of topic at hand. 2. Provide opportunities for researchers to present most recent data without compromising future publications. 3. Foster collaboration. 4. Encourage creativity in developing research strategies. 5. Provide opportunities for students and junior faculty to participate in the process. 6. Facilitate development of novel approaches to disease prevention, progression and treatment, which can be tested.
描述(由申请人提供):维克森林大学健康科学的妇女健康中心于1995年开始举办关于妇女健康的年度格雷林会议,以进行尖端的妇女健康研究。过去的会议集中在雌激素对动脉粥样硬化和认知能力下降的发病机制和预防的影响,并成功地传播了关于雌激素,心脏病和认知能力的新研究。今年,我们正在扩大我们的关注点,将一整天的时间专门用于激素治疗和认知。妇女的认知健康将纳入认知健康的新问题,概述激素的风险和益处以及它们如何影响妇女的认知健康。会议还将研究女性中更常见的疾病及其治疗对认知功能的影响,探索认知衰退基础科学的进展,并调查诊断标准的进展以及新的预防和治疗方法。会议的目标是汇集该领域的领导者,审查当前的知识,以指导有前途的研究途径的努力。妇女认知健康将于2003年10月29日至31日在北卡罗来纳州温斯顿-塞勒姆举行。会议将在无障碍的Graylyn会议中心举行,那里有40个房间为外地客人保留。参加者可以飞往北卡罗来纳州格林斯伯勒的皮埃蒙特三合会国际机场。将为发言者提供机场班车服务,与会者往返票价为39美元。报名人数限制为100名演讲者和与会者,以促进互动。一个海报会议将突出在方法和认知衰退和痴呆症的研究的最新进展,并奖励将给予最优秀的学生和初级教师提交,以鼓励新的研究人员的工作。 目的和目标: 1.通过召集一个对当前主题有专门知识的小组,扩大知识库,从中得出解决方案。 2.为研究人员提供展示最新数据的机会,而不影响未来的出版物。 3.促进合作。 4.在制定研究策略时鼓励创造性。 5.为学生和初级教师提供参与这一过程的机会。 6.促进疾病预防、进展和治疗的新方法的开发,这些方法可以进行测试。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sally Ann SHUMAKER其他文献

Sally Ann SHUMAKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sally Ann SHUMAKER', 18)}}的其他基金

TAS::75 0843::TAS HORMONE THERAPY AND COGNITIVE AGING IN OLDER AND YOUNGER POSTM
TAS::75 0843::TAS 激素治疗与老年人和年轻人 POTM 中的认知老化
  • 批准号:
    8503555
  • 财政年份:
    2011
  • 资助金额:
    $ 3.64万
  • 项目类别:
TAS::75 0843::TAS HORMONE THERAPY AND COGNITIVE AGING IN OLDER AND YOUNGER POSTM
TAS::75 0843::TAS 激素治疗与老年人和年轻人 POTM 中的认知老化
  • 批准号:
    8333760
  • 财政年份:
    2011
  • 资助金额:
    $ 3.64万
  • 项目类别:
HHSN268201100004C, MODIFICATION #5, 3-8470187 OPTION PERIOD 2 BASE, PERIOD OF PER
HHSN268201100004C,修改
  • 批准号:
    8756939
  • 财政年份:
    2010
  • 资助金额:
    $ 3.64万
  • 项目类别:
12th Biennial Graylyn Conference on Women's Cognitive Health
第十二届两年一度的格雷林妇女认知健康会议
  • 批准号:
    7806199
  • 财政年份:
    2009
  • 资助金额:
    $ 3.64万
  • 项目类别:
Hormone Therapy and Cognitive Aging in Older and Younger Postmenopausal Women: E
老年和年轻绝经后妇女的激素治疗和认知衰老:E
  • 批准号:
    8340470
  • 财政年份:
    2007
  • 资助金额:
    $ 3.64万
  • 项目类别:
Graylyn Conference on Women's Cognitive Health
格雷林妇女认知健康会议
  • 批准号:
    7407346
  • 财政年份:
    2007
  • 资助金额:
    $ 3.64万
  • 项目类别:
10th Annual Graylyn Conference on Women's Cognitive Health
第十届格雷林妇女认知健康年度会议
  • 批准号:
    7001793
  • 财政年份:
    2005
  • 资助金额:
    $ 3.64万
  • 项目类别:
Women's Health Initiative Memory Study (WHIMS)
女性健康倡议记忆研究 (WHIMS)
  • 批准号:
    7824221
  • 财政年份:
    2003
  • 资助金额:
    $ 3.64万
  • 项目类别:
7th Annual Graylyn Conference: Women's Cognitive Health
第七届格雷林年度会议:女性认知健康
  • 批准号:
    6418349
  • 财政年份:
    2001
  • 资助金额:
    $ 3.64万
  • 项目类别:
CORE--MEDICAL OUTCOMES AND SOCIAL SCIENCES
核心——医疗结果和社会科学
  • 批准号:
    6482405
  • 财政年份:
    2001
  • 资助金额:
    $ 3.64万
  • 项目类别:

相似海外基金

Hormone Therapy for Peri- and Postmenopausal Women with HIV (HoT)
感染艾滋病毒的围绝经期和绝经后妇女的激素治疗 (HoT)
  • 批准号:
    10698682
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
Understanding the effects of cross-sex hormone therapy on vaginal mucosal immunity
了解跨性别激素治疗对阴道粘膜免疫的影响
  • 批准号:
    10749174
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
A Mouse Model to Test the Effects of Gender-affirming Hormone Therapy on HIV Vaccine-induced Immune Responses
测试性别肯定激素疗法对 HIV 疫苗诱导的免疫反应影响的小鼠模型
  • 批准号:
    10748892
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
Individualized estimates of treatment benefit from hormone therapy for men with prostate cancer
前列腺癌男性激素治疗获益的个体化评估
  • 批准号:
    10739866
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
Cardiovascular Health in Transgender Hormone-Therapy Research Priority Setting
跨性别激素治疗研究中的心血管健康优先事项设定
  • 批准号:
    480849
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
    Miscellaneous Programs
Understanding the effects of Gender Affirming Hormone Therapy (GAHT) on immune function using a systems immunology approach
使用系统免疫学方法了解性别肯定激素疗法 (GAHT) 对免疫功能的影响
  • 批准号:
    10749957
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
The effects of masculinizing gender-affirming hormone therapy for transgender men on susceptibility to HIV-1 infection modelled ex vivo in cervical mucosal tissue
跨性别男性男性化性别肯定激素治疗对子宫颈粘膜组织离体 HIV-1 感染易感性的影响
  • 批准号:
    10748946
  • 财政年份:
    2023
  • 资助金额:
    $ 3.64万
  • 项目类别:
Mechanistic basis of urinary Lactobacillus enrichment by estrogen hormone therapy
雌激素治疗增加尿乳酸菌的机制基础
  • 批准号:
    10670681
  • 财政年份:
    2022
  • 资助金额:
    $ 3.64万
  • 项目类别:
Thrombosis Risk in Transgender Adolescents and Young Adults Starting Gender-Affirming Hormone Therapy
开始性别肯定激素治疗的跨性别青少年和年轻人的血栓形成风险
  • 批准号:
    10674629
  • 财政年份:
    2022
  • 资助金额:
    $ 3.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了